Upadacitinib
Especificaciones
1310726-60-3Número CAS
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamideNombre IUPAC
C17H19F3N6OFórmula química
380.4 g/molPeso molecular
Upadacitinib; 1310726-60-3; ABT-494; Upadacitinib anhydrous; 4RA0KN46E0; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; DTXSID901027919; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; upadacitinibum; RefChem:57163; L04AA44; DTXCID401513480; (3S,4R)-3-ethyl-4-(1,5,7,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; Rinvoq; (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; ABT 494; UNII-4RA0KN46E0; C17H19F3N6O; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; Upadacitinib [USAN]; Upadacitinib (Standard); UPADACITINIB [MI]; Upadacitinib, ABT-494; Upadacitinib (USAN/INN); UPADACITINIB [INN]; Upadacitinib [USAN:INN]; Upadacitinib (ABT-494); UPADACITINIB [WHO-DD]; GTPL9246; orb1299762; SCHEMBL9991056; CHEMBL3622821; WYQFJHHDOKWSHR-MNOVXSKESA-N; GLXC-10425; UPADACITINIB [ORANGE BOOK]; EX-A1628; BDBM50503287; EBC-26865; HY-19569R; s8162; AKOS030567686; CS-6150; DB15091; ABBV-599 COMPONENT UPADACITINIB; NCGC00588874-01; AC-30326; AS-56379; DA-78788; FA166721; HY-19569; NS00133778; T7503; C72237; D10994; F797290; Q27074125; Z2831495606; (3S,4R)-3- Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide; 1831899-72-9; ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; rel-(3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamideSinónimos
Productos que contienen Upadacitinib
CHEMISTRY Discover Molecule InsightsUpadacitinib(Semihydrate)Upadacitinib TabletsUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUPADACITINIB
Página 1 de 3
Servicios relacionados con Upadacitinib
Empresas que venden Upadacitinib
HR
Hangzhou Royall Import & Export Co.,LtdChinaJM
Jiangsu Magic Biotechnology Co., LtdChinaCP
CHENGHUI PHARMACEUTICAL GROUP LTDChinaSI
Sinoway Industrial Co.Ltd.ChinaSI
Shanghai IntVal Chemicals Co., LtdChinaRG
ROUNDCARE GROUPChinaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChinaSG
Sichuan Gowell Pharmaceutical Co., Ltd.ChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChinaPágina 1 de 2